By Chris Bailey | Tuesday 28 July 2020
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
A year ago almost to the day, I observed about health and hygiene company Reckitt Benckiser (RB.) that ‘this one has always been a buy for me in the lower £60s range’. Well despite going via the mid £50s in the early days of the market decline, this has ultimately worked out well as you would expect from a company whose brands include Dettol, Vanish, Nurofen, Finish, Harpic and Durex. Many would have regarded at least one – if not more – of these products as ‘must-haves’ during the darkest days of the pandemic. So no great surprise to see today’s first half numbers being described as showing a ‘strong underlying performance coupled with Covid-19 tailwinds’…
Already a subscriber? Click here to sign in
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
Search ShareProphets |
Stock market news |
Recent Comments |
Site by Everywhen
